Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended March 31, 2019 after the market closes on Tuesday, April 23, 2019, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
April 9, 2019
· 1 min read